Sandbox GGC12: Difference between revisions
James Nolan (talk | contribs) No edit summary |
No edit summary |
||
| Line 19: | Line 19: | ||
The structural highlights of this protein are four: the six subdomains that compose the protein, the binding site in domain II for salicylates, sulfonamides and several drug ingredients, the bilirubin binding site at position 264, and the free cysteine in the structure of the protein <ref> PMID: 32162429</ref>. | The structural highlights of this protein are four: the six subdomains that compose the protein, the binding site in domain II for salicylates, sulfonamides and several drug ingredients, the bilirubin binding site at position 264, and the free cysteine in the structure of the protein <ref> PMID: 32162429</ref>. | ||
This is the structural view of <scene name='78/781196/Six_subdomains/1'>HSA six subdomains</scene> by different colors. nd another to make <scene name="/12/3456/Sample/2"> by different colors. a transparent representation</scene> of the protein. | This is the structural view of <scene name='78/781196/Six_subdomains/1'>HSA six subdomains</scene> by different colors. nd another to make <scene name="/12/3456/Sample/2"> by different colors. a transparent representation</scene> of the protein. The shared binding site in domain II between zinc and calcium at residue Asp 273 suggests a crosstalk between zinc and calcium transport in the blood. | ||
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> | ||